American Medical Assn. Calls For ‘Pot’ Review

The American Medical Association adopted a new policy on marijuana last week.

 HOUSTON, Texas — The American Medical Association adopted a new policy on marijuana last week.

The AMA’s House of Delegates is now calling for “marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods.”

In layman’s terms, that means the AMA wants the Feds to see about making marijuana redesignated as having a “medical benefit.”

However, this change of policy does not mean the organization supports marijuana legailzation.

The federal government still places marijuana in the same drug category as heroin and LSD with no medical benefits.

However, cocaine and methamphetamines are designated as having some clinical benefits in certain instances.

Aaron Houston, director of government relations for the Marijuana Policy Project, referred to the AMA’s new policy as “historic.”

The AMA is considered to be a “conservative major medical organization,” he said.

The American College of Physicians, the country’s second-largest medical group, has already proposed a review of marijuana’s status.